Metraipolis › archive › dc_8aeb63b026ef

Beyond anti-VEGF: expanding the therapeutic horizon and biomarker landscape in retinopathy of prematurity — Europe PMC PMID:41695116

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41695116
DOI: 10.3389/fped.2025.1713783
License (as archived): solo-consultazione
Archived: 2026-11-06T09:56:26.285Z
SHA-256 of the archived text: 58ff0577796758c77d1178a1f8d7ddea3c85d4721112ba7374edc5a743820931
Stable URL of this page: https://metraipolis.com/documento/dc_8aeb63b026ef

How to cite

Beyond anti-VEGF: expanding the therapeutic horizon and biomarker landscape in retinopathy of prematurity — Europe PMC PMID:41695116 — Europe PMC (en), https://europepmc.org/article/MED/41695116 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8aeb63b026ef (Metraipolis archive dc_8aeb63b026ef, sha256 58ff0577796758c77d1178a1f8d7ddea3c85d4721112ba7374edc5a743820931)

BibTeX

@misc{dc8aeb63b026ef,
  title = {Beyond anti-VEGF: expanding the therapeutic horizon and biomarker landscape in retinopathy of prematurity — Europe PMC PMID:41695116},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41695116},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8aeb63b026ef; sha256 58ff0577796758c77d1178a1f8d7ddea3c85d4721112ba7374edc5a743820931},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41695116. Agents can read the archived copy with the MCP tool read_document.